Viking Therapeutics
VKTX
VKTX
361 hedge funds and large institutions have $1.87B invested in Viking Therapeutics in 2025 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 138 increasing their positions, 105 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 390 → 361 (-29)
26% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 69
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
361
Holding in Top 10
1
Calls
$242M
Puts
$114M
Top Buyers
| 1 | +$26.9M | |
| 2 | +$20.3M | |
| 3 | +$19.4M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$16.2M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$13.1M |
Top Sellers
| 1 | -$106M | |
| 2 | -$18.9M | |
| 3 | -$17.8M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$16.9M |
| 5 |
DFO
Duquesne Family Office
New York
|
-$14.6M |
